Table 1.
Demographic and Clinical Variables
| M ± SD | Range | n (%) | |
|---|---|---|---|
| Age at participation | 9.84 ± 4.74 | 0–21 | |
| Gender (male) | 50 (48.08) | ||
| Race | |||
| Caucasian | 68 (65.40) | ||
| African American | 16 (15.40) | ||
| Asian | 4 (3.80) | ||
| Othera | 16 (15.40) | ||
| HIb | |||
| Grade 1 | 18 (17.30) | ||
| Grade 2 | 28 (26.90) | ||
| Grade 3 | 58 (55.80) | ||
| Number of surgeries (median) | 1.00 | 0–8 | |
| Extent of surgery | |||
| None | 12 (11.54) | ||
| Catheter | 17 (16.35) | ||
| Resection | 75 (72.12) | ||
| CSF diversionc (present) | 34 (32.69) | ||
| DId (present) | 55 (52.88) | ||
| Vision status | |||
| Visual fields | |||
| Intact bilaterally | 67 (64.40) | ||
| Unilateral field defect | 7 (6.70) | ||
| Bilateral field defect | 22 (21.20) | ||
| Unassessablee | 8 (7.70) | ||
| Visual acuity | |||
| No deficits | 76 (73.10) | ||
| Reduced vision, no impairmentf | 10 (9.60) | ||
| Reduced vision, impairmentf | |||
| Unilateralg | 6 (5.80) | ||
| Bilateralg | 10 (9.60) | ||
| Blindh | 1 (0.96) | ||
| Unassessablee | 1 (0.96) |
HI=hypothalamic involvement; CSF=cerebrospinal fluid; DI=diabetes insipidus
a
Other race was composed of participants with race marked as “Unknown”
b
Grade 1=no HI; Grade 2=anterior HI; Grade 3=anterior and posterior HI including mammillary bodies
c
Includes ventriculoperitoneal shunting and endoscopic third ventriculostomy
d
Determined based on whether patient was prescribed desmopressin prior to baseline cognitive evaluation
e
As a result of age, behavioral difficulties, and blindness
f
Reduced vision unilaterally and bilaterally
g
Includes unilateral blindness
h
Bilaterally